Status:
RECRUITING
Paclitaxel (Albumin Bound),Bleomycin And Cisplatin Or Carboplatin for Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck
Lead Sponsor:
Sun Yat-sen University
Conditions:
Squamous Cell Carcinoma Of The Head And Neck
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
The purpose of this single arm, phase Ⅱ clinical trail is to determine the safety and efficacy of paclitaxel (albumin bound),bleomycin and cisplatin or carboplatin in the treatment of recurrent Or met...
Eligibility Criteria
Inclusion
- biopsy proved squamous cell carcinoma of the head and neck;
- stage IVc according to Union for International Cancer Control (UICC) edition VIII, or recurrent disease after chemotherapy and/or radiotherapy;
- 18 years or older; without other malignancy;
- proper functioning of the major organs.
Exclusion
- allergic to paclitaxel (albumin bound) or bleomycin or cisplatin or carboplatin ;
- female within gestation period or lactation;
- patients received drug of other clinical trial within 3 months
Key Trial Info
Start Date :
February 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 15 2026
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT03830385
Start Date
February 15 2019
End Date
February 15 2026
Last Update
July 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Guangzhou, Guangdong, China